Racial differences in endotoxin-induced tissue factor-triggered coagulation

被引:30
|
作者
Mayr, F. B. [1 ,4 ]
Spiel, A. O. [1 ]
Leitner, J. M. [1 ]
Firbas, C. [1 ]
Jilma-Stohlawetz, P. [2 ]
Chang, J. -Y. [3 ]
Key, N. S. [3 ]
Jilma, B. [1 ,5 ]
机构
[1] Med Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, A-1090 Vienna, Austria
[3] Univ N Carolina, Div Hematol Oncol & Transplantat, Chapel Hill, NC USA
[4] Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA USA
[5] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
关键词
coagulation; Duffy antigen; endotoxin; MCP-1; tissue factor; DUFFY ANTIGEN; INFLAMMATION; ACTIVATION; INHIBITOR; HUMANS; CELLS; PHARMACODYNAMICS; FIBRINOLYSIS; POLYMORPHISM; EXPRESSION;
D O I
10.1111/j.1538-7836.2009.03307.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Racial differences in coagulation are poorly understood. While some studies suggest a 'prothrombotic' coagulation profile in blacks compared with whites, others report an increased bleeding risk for blacks in various clinical settings. Moreover, preclinical data suggest a link between the Duffy antigen (= DARC, Duffy antigen receptor of chemokines) and coagulation. Objectives: Based on our previous research in Duffy antigen negative Africans, we hypothesized that Africans have an attenuated procoagulant response compared with Caucasians in a model of lipopolysaccharide (LPS)-induced, tissue factor (TF)-triggered coagulation activation. Patients/methods: Healthy male volunteers (16 Duffy-negative Africans, 16 Duffy-positive Caucasians) received 2 ng kg(-1) LPS, and outcome parameters were measured using enzyme immunoassays and real-time polymerase chain reaction (RT-PCR, Taqman). Results: LPS increased microparticle (MP)-associated TF procoagulant activity (PCA) less in Africans than Caucasians. Africans had reduced in vivo thrombin formation compared with Caucasians: they generated less thrombin-antithrombin (TAT) complexes (10.4 pg mL(-1) vs. 23.0 pg mL(-1), P < 0.0001) and less prothrombin fragments (F1+2) (337 pmol mL(-1) vs. 819 pmol mL(-1), P < 0.0001). Consistently, Africans also had decreased fibrin formation (d-dimer: 0.3 pg mL(-1) vs. 0.5 pg mL(-1), P = 0.02). Conclusion: Duffy-negative subjects of African descent have a markedly reduced procoagulant response in a model of LPS-induced, TF-triggered coagulation activation compared with Duffy-positive healthy Caucasians.
引用
收藏
页码:634 / 640
页数:7
相关论文
共 50 条
  • [1] Influence of bivalirudin on tissue factor-triggered coagulation
    Butenas, saulius
    Orfeo, Thomas
    Brummel-Ziedins, Kathleen E.
    Mann, Kenneth G.
    BLOOD COAGULATION & FIBRINOLYSIS, 2007, 18 (05) : 407 - 414
  • [2] Characterization and development of factor XIIA inhibitors for assaying tissue factor-triggered coagulation
    Kolyadko, V
    Vuimo, T. A.
    Surov, S. S.
    Ovsepyan, R. A.
    Korneeva, V. A.
    Vorobiev, I. I.
    Orlova, N. N.
    Minakhin, L.
    Kuznedelov, K.
    Severinov, K.
    Ataullakhanov, F. I.
    Panteleev, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 45 - 45
  • [3] Simvastatin blunts endotoxin-induced tissue factor in vivo
    Steiner, S
    Speidl, WS
    Pleiner, J
    Seidinger, D
    Zorn, G
    Kaun, C
    Wojta, J
    Huber, K
    Minar, E
    Wolzt, M
    Kopp, CW
    CIRCULATION, 2005, 111 (14) : 1841 - 1846
  • [4] MECHANISM OF ENDOTOXIN-INDUCED COAGULATION ACCELERATION
    HOROWITZ, HI
    HOOK, EW
    DESPREZ, RM
    JOURNAL OF CLINICAL INVESTIGATION, 1961, 40 (06): : 1050 - &
  • [5] ENDOTOXIN-INDUCED INTRAVASCULAR COAGULATION IN RABBITS
    JENSEN, OM
    BUITRAGO, B
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1967, S : 47 - &
  • [6] Nicotinamide inhibits endotoxin-induced monocyte tissue factor expression
    Ungerstedt, JS
    Heimersson, K
    Söderström, T
    Hansson, M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (12) : 2554 - 2560
  • [7] Pharmacokinetic/Pharmacodynamic modelling as a tool to define safe dosing regimens for evaluation of dose response of tanogitran (BIBT 986), a novel small molecule parenteral anticoagulant, in a model of endotoxin-induced, tissue factor-triggered coagulation activation in human beings
    Schuehly, U.
    Graefe-Mody, E. U.
    Liesenfeld, K. H.
    Leitner, J. M.
    Mayr, F. B.
    Rathgen, K.
    Staehle, H.
    Jilma, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 375 - 375
  • [8] Heparin blunts endotoxin-induced coagulation activation
    Pernerstorfer, T
    Hollenstein, U
    Hansen, JB
    Knechtelsdorfer, M
    Stohlawetz, P
    Graninger, W
    Eichler, HG
    Speiser, W
    Jilma, B
    CIRCULATION, 1999, 100 (25) : 2485 - 2490
  • [9] THE EFFECT OF 2-DOMAIN TISSUE FACTOR PATHWAY INHIBITOR ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RABBITS
    BREGENGARD, C
    NORDFANG, O
    WILDGOOSE, P
    SVENDSEN, O
    HEDNER, U
    DINESS, V
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) : 699 - 706
  • [10] Lepirudin blunts endotoxin-induced coagulation activation
    Pernerstorfer, T
    Hollenstein, U
    Hansen, JB
    Stohlawetz, P
    Eichler, HG
    Handler, S
    Speiser, W
    Jilma, B
    BLOOD, 2000, 95 (05) : 1729 - 1734